P
PJP icon

&Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

&Partners’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
5,466
+481
+10% +$52K ﹤0.01% 1684
2026
Q1 		$517K Buy
4,985
+1,617
+48% +$171K ﹤0.01% 1675
2025
Q4 		$352K Buy
3,368
+5
+0.1% +$503 ﹤0.01% 1822
2025
Q3 		$311K Sell
3,363
-192
-5% -$16.8K ﹤0.01% 1728
2025
Q2 		$284K Sell
3,555
-4
-0.1% -$319 ﹤0.01% 1652
2025
Q1 		$300K Sell
3,559
-157
-4% -$13.4K ﹤0.01% 1412
2024
Q4 		$310K Sell
3,716
-7
-0.2% -$602 ﹤0.01% 1323
2024
Q3 		$324K Sell
3,723
-18
-0.5% -$1.54K 0.01% 1065
2024
Q2 		$308K Buy
+3,741
New +$297K 0.01% 706

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

&Partners's PJP Position: Q2 2026 in Review

&Partners increased its Invesco Pharmaceuticals ETF (PJP) stake by 9.6% in Q2 2026, buying an estimated $52K and bringing the position to 5,466 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

&Partners first reported a position in PJP in Q2 2024 and has held it in 9 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • &Partners held 5,466 shares of Invesco Pharmaceuticals ETF worth $647K as of Q2 2026.
  • &Partners bought 481 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $52K.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1684 holding.
  • &Partners first reported a position in Invesco Pharmaceuticals ETF in Q2 2024 and has held it in 9 quarters since.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.